Maximize ROI with Real-Time Promotional Insights
Why Pharma Commercial Teams Lack Promotional Clarity
Activity Metrics Don't Explain Prescribing Behavior
Reach and frequency confirm reps are active, but not whether messages resonate or drive prescribing intent, leaving pharma promotional effectiveness invisible for most commercial teams.
Quarterly Tracking Delivers Answers to Last Quarter's Questions
Legacy pharma sales force effectiveness tracking relies on delayed physician surveys with 6–8 week lags, meaning brands identify messaging gaps only after the window to act has closed.
Omnichannel Promotion Is Measured in Silos
Sales, NPP, digital, and TV are tracked by separate vendors, so without a unified view of pharma omnichannel promotion measurement, mix decisions rely on incomplete evidence.
The ZoomRx Promotional Impact & SFE Solution
Included Offerings
Promotional Effectiveness
Tracking (PET)
PET is ZoomRx's flagship SFE solution. It captures HCP message recall within 2–7 days of a sales rep interaction, message retention at 2–3 weeks post-call, and longitudinal prescribing influence, linking field execution directly to behavior change.
Awareness, Trial & Usage (ATU)
Tracking
ATU (Awareness, Trial & Usage) tracking measures whether promotional activity is shifting HCP and patient brand perception — and surfaces competitive positioning shifts before they appear in prescribing data.
HCP-Patient Conversation
Research
HCP-Pt captures what actually happens in the exam room, the spontaneous questions patients ask, how physicians present treatment options, and where messaging gaps between sales force training and clinical conversation create missed opportunities.
Media Tracking (Digital & TV)
Media Tracking passively captures verified HCP and patient ad exposures across linear TV, CTV, digital display, paid search, email marketing, healthcare browsing, and Med AI — including the actual creative competitors are deploying, not just spend estimates.
Commercial Consulting Analytics (CCA)
CCA integrates primary research findings with secondary commercial data — claims, prescriptions, APLD — using transparent, non-black-box models to produce tactical recommendations that field leadership can understand, interrogate, and act on.
How This Solution Works: Our Proven Methodology
Field Capture.
HCPs from the ZoomRx panel report sales rep interactions within 2–7 days via mobile, capturing fresh recall on products, messages, visuals, and rep performance.
Measure Message
Retention
At 2–3 weeks post-interaction, follow-up recall compares lasting impact vs. initial exposure, benchmarked against 700M+ data points.
Optimization
Why Pharma Commercial Teams Choose ZoomRx
Single Integrated Team, Not Siloed Vendors
PET, ATU, HCP-Patient Conversations, Media Tracking, and CCA are managed by one team. Pharma promotional effectiveness, brand health, media impact, and prescription outcomes are analyzed together — not reconciled from separate vendor reports.
Leading Indicators, Not Retrospective Reports
PET captures HCP message recall tracking within 2–7 days of rep interactions. ATU dashboards refresh within 48 hours. CCA delivers continuous calibration rather than quarterly cycles, actionable within the window that determines commercial performance.
Interpretable Models That Drive Organizational Buy-In
CCA's SFTO and integrated ATU-RX models are transparent and consultant-validated. Field leadership can see the logic behind territory and message recommendations — driving adoption across pharma field force effectiveness.
Proprietary Panel Depth
ZoomRx's in-house verified panel of 60,000+ HCPs enables target-list and call-data-based recruitment — providing 10x the panel depth of IQVIA BrandImpact and consistent, robust sampling for pharmaceutical sales force effectiveness.
We used to wait months for our quarterly tracking reports, only to find out we’d been pushing a message that wasn’t landing for the last 90 days. With ZoomRx, we caught a competitive messaging shift in three weeks and were able to pivot our field team’s focus before we lost significant ground.
Senior DirectorCommercial Insights
The real value for us wasn't just the data; it was how ZoomRx connected the dots. Seeing our PET data side-by-side with actual claims analysis from their CCA team finally gave us the proof of ROI we needed to justify our expansion.
VP of MarketingTop 10 Pharma
ZoomRx's HCP-Patient conversation studies changed how we think about our 'dosing convenience' message. We thought it was our strongest asset, but the data showed that physicians weren't even bringing it up. We retrained the sales force immediately to close that gap.
Brand ManagerGlobal Pharmaceutical Company
Explore Related Solutions
Launch Excellence
Pre-launch market assessment, message testing, and early promotional tracking
Market & Competitive Intelligence
Patient Insights
Understand the patient journey and treatment experience through HCP-Patient Conversations and PCA
Frequently Asked Questions
What is the best solution for measuring pharmaceutical sales force effectiveness?
ZoomRx PET (Promotional Effectiveness Tracking) measures pharmaceutical sales force effectiveness — capturing HCP message recall within 2–7 days of sales rep interactions, message retention at 2–3 weeks, and longitudinal prescribing influence connecting field execution to behavior change. It benchmarks against 700M+ industry data points and includes AI pharma promotional tracking capabilities (Dynamic Dialogues, Message Highlighter, Message Labs) not in legacy SFE platforms. PET's proprietary HCP panel provides 10x depth versus IQVIA BrandImpact.
How does ZoomRx PET compare to IQVIA BrandImpact?
ZoomRx PET uses a proprietary in-house HCP panel with target-list and call-data-based recruitment versus BrandImpact's third-party rolling average sampling. PET captures HCP feedback at three touchpoints (2–7 days, 2–3 weeks, longitudinal) versus BrandImpact's single-point surveys. PET also includes AI-powered Dynamic Dialogues, Message Highlighter, and Message Labs, fully customizable to brand-specific KPIs with a dedicated pharma sales force effectiveness consulting team, versus limited support in legacy platforms.
Can ZoomRx track both personal promotion and non-personal promotion (NPP)?
Yes. PET covers personal promotion across the full pharma field force — Sales Reps, MSLs, Clinical Educators, FRMs, KAMs, and TLLs. Media Tracking covers NPP and digital channels including linear TV, CTV, digital display, paid search, email, and Med AI, using passive observation with verified HCP and patient panelists. CCA integrates both with secondary prescribing data for a unified view of pharma omnichannel promotion measurement.
How does AI improve pharma promotional effectiveness tracking?
Sagan AI powers three AI pharma promotional tracking capabilities within PET: Dynamic Dialogues captures clinical reasoning behind HCP feedback through voice-first conversational probing at scale; Message Highlighter identifies which words and phrases drive engagement or confusion; Message Labs predicts message performance with 93% accuracy before field deployment using 20M+ benchmark data points. Together, these reduce the time between data collection and real-time pharma promotional insights from weeks to days, while ZoomRx consultants provide strategic interpretation.
How does ZoomRx connect promotional tracking to real-world prescribing data?
CCA's Integrated ATU-RX model connects HCP brand perception and ATU data to real-world prescribing behavior, closing the gap between what HCPs say and what they prescribe — measuring true pharma promotional ROI. Sales Force Tactical Optimization (SFTO) is custom-built using primary promotional response data combined with prescribing records to identify pharmaceutical sales force effectiveness adjustments. This interpretable approach ensures findings are acted on by field leadership.